Afferent Pharmaceuticals logo

Afferent Pharmaceuticals

Advancing the science of chronic pain relief by targeting P2X3 receptors in nerve fibers

2-10 employees · est. 2009

VS
Radiomedix, Inc. logo

Radiomedix, Inc.

Innovating Theranostics

44 employees · est. 2006 · Houston, United States

Radiomedix, Inc. is the older company (2009 vs 2006); Radiomedix, Inc. is the larger of the two.

Side-by-Side Comparison

Afferent Pharmaceuticals Radiomedix, Inc.
Founded
2009 2006 older
Headquarters
Not tracked yet Houston, United States
Employees
2-10 44 larger
Industry
Biopharma, Biotechnology, Pharmaceutical Biotechnology, Health Care
Funding Stage
Series C Series A
Total Funding
$83.15M $40.00M
Funding Rounds
4 1
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Biopharmaceutical Company, Clinical-stage, Chronic Pain Relief, P2X3 Receptors, Nerve Fibers, AF-219, Phase 1 Clinical Studies, Drug Development, San Mateo, California, Neuroscience, Pain Management, Pharmaceutical Research, Medical Innovation Not tracked yet
Website
afferentpharma.com radiomedix.com
Afferent Pharmaceuticals logo

About Afferent Pharmaceuticals

Afferent Pharmaceuticals is a clinical-stage biopharmaceutical company focusing on developing treatments for chronic pain by targeting P2X3 receptors in nerve fibers. The company's key development, AF-219, has completed two Phase 1 clinical studies. Founded in 2009, Afferent Pharmaceuticals is based...

Radiomedix, Inc. logo

About Radiomedix, Inc.

Radiomedix, Inc. is a biotechnology company located in Houston, Texas. The company specializes in innovative targeted radio-pharmaceuticals for the diagnosis, monitoring, and therapy of cancer, with a focus on commercializing generator-produced radio-pharmaceuticals based on Gallium-68 chemistry. Ad...

We will tell you when either one moves

BounceWatch watches Afferent Pharmaceuticals and Radiomedix, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Afferent Pharmaceutica... and Radiomedix, Inc. — by email.

Frequently Asked Questions

Afferent Pharmaceuticals — Advancing the science of chronic pain relief by targeting P2X3 receptors in nerve fibers. Radiomedix, Inc. — Innovating Theranostics. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Afferent Pharmaceuticals has raised $83.15M while Radiomedix, Inc. has raised $40.00M.
Afferent Pharmaceuticals and Radiomedix, Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Afferent Pharmaceuticals with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Afferent Pharmaceuticals on 12 Sep 2024, and Radiomedix, Inc. on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes